Report for Sabo R

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : Formetanate toxicity and changes in antioxidant enzyme system of Apis mellifera larvae - Staron_2017_Environ.Sci.Pollut.Res.Int_24_14060
Author(s) : Staron M , Sabo R , Sobekova A , Sabova L , Legath J , Lohajova L , Javorsky P
Ref : Environ Sci Pollut Res Int , 24 :14060 , 2017
Abstract : Staron_2017_Environ.Sci.Pollut.Res.Int_24_14060
ESTHER : Staron_2017_Environ.Sci.Pollut.Res.Int_24_14060
PubMedSearch : Staron_2017_Environ.Sci.Pollut.Res.Int_24_14060
PubMedID: 28409431

Title : Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects - He_2008_J.Clin.Pharmacol_48_85
Author(s) : He YL , Ligueros-Saylan M , Sunkara G , Sabo R , Zhao C , Wang Y , Campestrini J , Pommier F , Dole K , Marion A , Dole WP , Howard D
Ref : Journal of Clinical Pharmacology , 48 :85 , 2008
Abstract : He_2008_J.Clin.Pharmacol_48_85
ESTHER : He_2008_J.Clin.Pharmacol_48_85
PubMedSearch : He_2008_J.Clin.Pharmacol_48_85
PubMedID: 17986525

Title : Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Sunkara_2007_J.Clin.Pharmacol_47_1152
Author(s) : Sunkara G , Sabo R , Wang Y , He YL , Campestrini J , Rosenberg M , Howard D , Dole WP
Ref : Journal of Clinical Pharmacology , 47 :1152 , 2007
Abstract : Sunkara_2007_J.Clin.Pharmacol_47_1152
ESTHER : Sunkara_2007_J.Clin.Pharmacol_47_1152
PubMedSearch : Sunkara_2007_J.Clin.Pharmacol_47_1152
PubMedID: 17656620

Title : The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin - He_2007_Eur.J.Clin.Pharmacol_63_677
Author(s) : He YL , Sabo R , Campestrini J , Wang Y , Ligueros-Saylan M , Lasseter KC , Dilzer SC , Howard D , Dole WP
Ref : European Journal of Clinical Pharmacology , 63 :677 , 2007
Abstract : He_2007_Eur.J.Clin.Pharmacol_63_677
ESTHER : He_2007_Eur.J.Clin.Pharmacol_63_677
PubMedSearch : He_2007_Eur.J.Clin.Pharmacol_63_677
PubMedID: 17486328

Title : Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects - He_2007_Curr.Med.Res.Opin_23_1131
Author(s) : He YL , Sabo R , Riviere GJ , Sunkara G , Leon S , Ligueros-Saylan M , Rosenberg M , Dole WP , Howard D
Ref : Curr Med Res Opin , 23 :1131 , 2007
Abstract : He_2007_Curr.Med.Res.Opin_23_1131
ESTHER : He_2007_Curr.Med.Res.Opin_23_1131
PubMedSearch : He_2007_Curr.Med.Res.Opin_23_1131
PubMedID: 17519080